Skip to main content

In my clinic, I treat patients with different types of lymphoma, including aggressive and indolent lymphomas. My specific clinical and research interest is in chimeric antigen receptor T-cell (CAR-T) therapy. I lead several CAR-T cell clinical trials in lymphoma and collaborate with our translational researchers to bring these novel therapies to the clinic. I am interested in innovative approaches to improve the efficacy and safety of CAR-T cell therapy as well as investigations of why some patients progress after treatment. I am also involved in multi-center clinical trials and research collaborations with the goal of improving treatment options and quality of life for patients with lymphoma.


UNC AFFILIATIONS:

(DOM) Hematology, Department of Medicine (DOM), Lineberger Cancer Center

CLINICAL/RESEARCH INTERESTS:

Clinical Trials, Gene Therapy, Immunology